Larissa J. Lubitz, Moritz P. Haffner, Harden Rieger, & Gero Leneweit. (2024). Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells. MDPI AG.
Chicago Style (17th ed.) CitationLarissa J. Lubitz, Moritz P. Haffner, Harden Rieger, and Gero Leneweit. Increased Cellular Uptake of ApoE3- or C(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells. MDPI AG, 2024.
MLA (9th ed.) CitationLarissa J. Lubitz, et al. Increased Cellular Uptake of ApoE3- or C(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells. MDPI AG, 2024.
Warning: These citations may not always be 100% accurate.